🏗️ Kinsale Capital (KNSL): The Optical Illusion Showing why the market is wrong
Wall Street has the attention span of a goldfish on espresso. 🐠☕️
If a company reports +30% growth, the crowd goes wild. If the next quarter it “only” reports +10%, the crowd panics and dumps the stock. This is exactly what’s playing out with Kinsale Capital (KNSL) and for those of us willing to look past the optical illusion, it’s a generational buying opportunity.
Let me show you why the market is wrong.
A Tier-1 Compounder Trading at Tier-3 Prices
MetricValuePrice $389.74 (as of Jan 28, 2026)
P/E Ratio:19.0x
Historical Avg P/E : 32.2x (5Y), 37.8x (10Y)
Earnings Yield : 5.25% (vs. 4.5% risk-free rate)
ROIC: 24.1%
ROE~25% (down from 31.8% in 2023)
Combined Ratio: 74.9% (industry avg: ~98%)
Translation: You’re buying a 24% ROIC insurance machine at a 41% discount to its historical valuation. The market thinks the growth story is dead. The market is wrong.
The Machine (What You’re Actually Buying)
The Plumbing Analogy:
Kinsale is like the boutique insurance shop for businesses nobody else wants to touch. They play in the Excess & Surplus (E&S) market—the “non-admitted” insurance world. Standard insurers (State Farm, Allstate) have to file their rates with regulators. Kinsale doesn’t. They’re free to write weird, risky stuff: haunted house liability, cannabis growers, AI startup cyber insurance, axe-throwing bars.
Here’s the genius: They’re a tech company disguised as an insurer. Their proprietary underwriting platform processes policies in minutes (vs. weeks for legacy carriers) with an Expense Ratio of ~21% (vs. industry average of 30%+). They say “no” to most business, cherry-pick the best risks, and print money.
The Two Engines:
Engine #1: Underwriting (The Ferrari)
This is the day-to-day business: writing policies, collecting premiums, paying claims.
Operating Earnings are still growing at ~20% even in 2025.
Their Combined Ratio of 74.9% means they make 25 cents on every dollar of premiums before investment income. Industry average? 98%. Most insurers barely break even on underwriting.
Engine #2: The Float (The Money Printer)
Between collecting premiums and paying claims (often years later), Kinsale holds billions in cash. This is “Float.”
They invest this Float in safe bonds. When rates were 5%+, this was free money.
The Problem (and Opportunity): Their Equity base has ballooned to $1.6B+ because they’re so profitable. It’s mathematically harder to earn a 30% return on $1.6B than on $500M. This is creating a temporary optical illusion.
The Moat (Why It’s Hard to Kill):
✅ Regulatory Moat: E&S insurers don’t compete with standard carriers by law.
✅ Tech Edge: Proprietary policy admin system = speed + low costs.
✅ Underwriting Discipline: A decade of data + algorithms = they only write profitable business.
✅ Scale Without Bloat: 674 employees generating $1.7B+ in revenue. That’s $2.5M+ per employee.
✅ Growing Market: E&S market expanding 10% annually as standard carriers retreat.
Part 2: The Optical Illusion (Why Wall Street Is Panicking)
Here’s where it gets fascinating. The market sees earnings growth slowing from 30% to 8-10% and screams, “The growth story is broken!” But if you understand the math, you realize this is a one-time normalization, not a structural problem.
The Math Behind the Illusion:
Let’s simulate how ROE compression creates a temporary growth slowdown:
Year 1 (The Party - 2023):
You start with $100 Equity.
ROE is 30%.
You make $30 profit.
Result: Equity grows to $130.
Year 2 (The Reset - 2025):
You start with $130 Equity.
ROE normalizes to 25% (still world-class, but lower).
Profit = $130 × 25% = $32.50.
The Optical Illusion: Profit grew from $30 to $32.50. That’s only +8% growth. 🐢
The Market Reaction:
“OMG! Growth collapsed from 30% to 8%! The business is broken! Sell!”
The Reality:
The business isn’t broken. The rate of return is just finding a sustainable floor. The company still got roughly 25% larger in terms of book value.
Year 3 (The Comeback - What Happens Next):
You kept the $32.50 profit. Equity is now $162.50.
ROE stays stable at 25%.
Profit = $162.50 × 25% = $40.60.
Boom. 💥 Growth snaps back. Going from $32.50 to $40.60 is a +25% increase.
We went from 30% (Year 1) ➡️ 8% (Year 2) ➡️ 25% (Year 3).
Part 3: The Waver Napkin Math (What You’ll Actually Make)
Now that we understand why the market is freaking out, let’s run the numbers on what you actually earn as a shareholder.
Growth Drivers (Next 5 Years):
Top-Line Growth: 10-12% GWP growth (Gross Written Premiums). Property is down -15% due to competition, but ex-property is up +12-14%.
Margin Expansion: As they scale, fixed costs get diluted. Combined ratio improving = 1-2% annual boost.
Investment Income: Float is growing + rates are still elevated. Adds ~2-3% to EPS growth.
Buybacks: $250M authorization (~2.7% of float). Adds ~2.5% annual EPS boost.
Total EPS Growth Estimate:
= 10% (top-line) + 2% (margin expansion) + 2% (investment income) + 2.5% (buybacks) = ~16-17% annual EPS growth
The Valuation Re-Rating Opportunity:
The market is paying 19x earnings today. Historical average? 32x (5Y), 38x (10Y).
Even if it only reverts halfway to normal (from 19x → 26x over 5 years), that’s a +6.5% annual boost just from multiple expansion.
Annual Valuation Boost=(2619)1/5−1=+6.5% per yearAnnual Valuation Boost=(1926)1/5−1=+6.5% per year
Waver’s Equation:
16.5% (Growth)+0.2% (Dividend)+6.5% (Multiple Expansion)=23.2% CAGR16.5% (Growth)+0.2% (Dividend)+6.5% (Multiple Expansion)=23.2% CAGR
Conservative Case (P/E stays at 19x):
16.5% + 0.2% = 16.7% CAGR → Still phenomenal.
Bear Case (P/E compresses to 16x):
16.5% + 0.2% - 3.5% = 13.2% CAGR → Still doubles the S&P 500’s long-term average.
Part 4: The Verdict
Rating: SCREAMING DISCOUNT ⭐⭐⭐⭐⭐
(This is a “back up the truck” situation)
The “Sleep Well at Night” Score: 9/10
Why it’s high:
✅ Best-in-class combined ratio (75%): They could weather a recession, catastrophe year, or rate collapse and still be profitable.
✅ ROIC of 24.1%, ROE of 25%+: Buffett-level capital efficiency.
✅ Capital-light model: Free cash flow is monstrous. No need to raise debt or equity.
✅ Niche positioning: They’re not competing with Berkshire or Chubb. Protected sandbox.
✅ Management: CEO Michael Kehoe founded the company in 2009 and owns 5% ($500M stake). Skin in the game.
Why it’s not a 10:
⚠️ California wildfire risk: $25M hit in Jan 2025. Catastrophe losses can spike.
⚠️ Property division headwinds: Largest division shrinking -15% GWP due to pricing competition.
⚠️ Interest rate sensitivity: ~30% of recent earnings growth came from investment income. If the Fed cuts aggressively, this tailwind fades.
Part 5: The Time Arbitrage Play
Here’s the magic. You only pay the “growth penalty” once. The market hates transition years where ROE resets. They look at EPS growth slowing and assume Engine #1 (Underwriting) has failed.
But if you look at the data:
Engine #1 is still pumping out +20% growth.
The slowdown is purely a mathematical function of Engine #2 (the massive capital base) adjusting to a new normal.
This is Time Arbitrage. Investors with a long-term horizon look at a “boring” year of 8-10% growth not as a failure, but as a coiled spring. As long as Kinsale maintains its tech advantage and keeps ROE above 20-25%, the laws of mathematics dictate that growth must accelerate again once ROE stabilizes.
The One-Liner:
“A Tier-1 compounder trading at a Tier-3 valuation. This is what you buy when everyone else is scared of insurance stocks. The plumbing is pristine, the price is a gift.”
What to Watch :
Q4 2025 Earnings (Feb 2026): Full-year results + 2026 guidance. If they beat and maintain ~10% GWP growth ex-property, this stock rips.
Combined Ratio Improvement: Every point of improvement = 5%+ EPS growth.
Buyback Acceleration: $250M authorized. If they lean in, the math gets even better.
E&S Market Share Gains: The E&S market is growing 10% annually. If KNSL can take share, 15-20% EPS growth is feasible.
Multiple Re-Rating: If the market wakes up and realizes this is a 25% ROE compounder trading at 19x P/E, watch for a snap-back to 23-25x.
Waver’s Final Take:
This is the kind of stock you buy and forget for 5 years. The business is boring (insurance admin), but the numbers are beautiful. For context:
Progressive (PGR): 30x P/E, 12% ROE.
Travelers (TRV): 14x P/E, but 98% combined ratio (barely profitable on underwriting).
Markel (MKL): 25x P/E, 10% ROE.
Kinsale is cheaper than all of them and more profitable than all of them. The only reason it’s unloved:
It’s small ($9B market cap).
It doesn’t pay a fat dividend (0.17% yield).
Insurance stocks are boring, and retail investors don’t understand combined ratios or ROIC.
The optical illusion: Wall Street sees 8% growth and panics, not realizing it’s a one-time mathematical artifact.
Action:
Buy aggressively below $400.
If it dips below $350, sell your couch.
At $390, you’re getting a 23% CAGR over 5 years (assuming modest multiple expansion).
If the market re-rates this to 25-30x P/E (where it traded 2020-2023), you’re looking at 30%+ annualized returns.
Shareholder Yield (2.9%) is meh, but you’re here for the compounding. This is the anti-meme stock—no hype, no Reddit mentions, just a machine printing cash in a boring corner of the market.
The Bottom Line:
Sometimes, you have to be willing to hold through the optical illusion to capture the compounding on the other side. The market hates “Year 2.” They hate transition years where ROE resets. But if you understand the physics of capital allocation, you realize this isn’t a failure—it’s a setup.
The growth hasn’t disappeared. It’s just coiled, waiting for ROE to stabilize. And when it does? The math is unforgiving. A 25% ROE business compounding at scale will print money for decades.
If you own it: Hold it and add on any dip below $370. This is a 10-year hold.
If you don’t: Start building a position. This is a compounder masquerading as a value stock. By the time Wall Street figures it out, it’ll be back at $500+.
Disclaimer: This is not financial advice. I’m just a dude who likes spreadsheets and insurance combined ratios.